Effects of TRPV1 Receptor Ligands on Nicotine-Induced Depression in Mice
Author Information
Author(s): Hayase Tamaki
Primary Institution: Department of Legal Medicine, Kyoto University, Kyoto, Japan
Hypothesis
The study examines the effects of TRPV1 ligands on nicotine-induced depression-like behaviors in a mouse model.
Conclusion
TRPV1 agonists significantly attenuated nicotine-induced depression-like behaviors, suggesting their potential therapeutic role.
Supporting Evidence
- TRPV1 agonists capsaicin and olvanil significantly reduced depression-like behaviors in mice.
- TRPV1 antagonist capsazepine did not show any antidepressant-like effects.
- The synthetic hybrid agonist arvanil exhibited strong antidepressant-like effects.
- Nicotine treatment caused significant increases in immobility times in behavioral tests.
Takeaway
This study found that certain substances can help reduce feelings of sadness caused by nicotine in mice.
Methodology
Mice were treated with nicotine and various TRPV1 ligands, and their behaviors were assessed using forced swimming and tail suspension tests.
Limitations
The study was conducted only in male mice, which may limit the generalizability of the findings.
Participant Demographics
Male ICR mice, approximately 80 days old.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website